Starpharma after 22 years, page-28

Some of us have been trying to tell the fan club this each time one of these non financial laboratory test agreements are signed but they won't have it .... it's all sunshine and rainbows if you listen to them

IMO we are likely to see an opportunistic takeover soon after we get the boot from the ASX300 ... probably in the vicinity of $2 to $3 ... certainly won't have been worth the wait if that happens but I guess that's what can happen when you let the fox (Merck) into the hen house - just ask Viralytics after they signed an agreement with Merck and then they watched their share price get beaten down to $0.75 and then Merck successfully bought them out for $1.75

I agree with @Joelsmith2452 's post above


https://www.fiercebiotech.com/biote... is set to pay,Keytruda in early-phase trials.
Merck inks $394M takeover of oncolytic virus play Viralytics
Feb 21, 2018 05:39am